CBPO  China Biologic Products Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Market Cap.

2.75B

Vuru Grade

67.23/100

Current Price

$110.54
+0.40 (+0.36%)

Growth Price

$42.47
Overvalued by 61.58%

Stability Price

$19.77
Overvalued by 82.11%

Company Metrics

  • 38.21 P/E
  • 10.64 P/S
  • 11.56 P/B
  • 2.89 EPS
  • 31.13% Cash ROIC
  • 0.67 Cash Ratio
  • 0 / N/A % Dividend
  • 100,875.00 Avg. Vol.
  • 24.88M Shares
  • 2.75B Market Cap.

Company Description

China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Today China Biologic Products (CBPO) Hits New Lifetime High
TheStreet.com - May 11, 2015
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
China Biologic Products' (CBPO) CEO David Gao on Q1 2015 Results ... - Seeking Alpha
China Biologic Products (CBPO) Hits New Lifetime High Today
TheStreet.com - May 22, 2015
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
China Biologic Products Q4 2014 Earnings: Primed For A Sell-Off? (CBPO)
Seeking Alpha (registration) - Feb 23, 2015
Before Q2 earnings on August 5, I wrote a bullish article on China Biologic Products (NASDAQ:CBPO), with a thesis stating that the company's plasma-based products should benefit from increasing market demand in China for Q2. I argued that the company's ...
Earnings Watchlist - China Biologic Products, Inc. (NASDAQ:CBPO)
The Markets Daily - Apr 20, 2015
As China Biologic Products, Inc. (NASDAQ:CBPO) prepares to next report their earnings on or around 2015-05-05, investors will be keeping a close eye on the reported earnings per share figure and how it compares to the Wall Street analyst consensus ...
Moving Stocks: Solazyme, Inc. (NASDAQ:SZYM), China Biologic Products, Inc ... - Stock Transcript
Sell-side Focus: China Biologic Products, Inc. (NASDAQ:CBPO)
Markets Daily - May 26, 2015
The consensus EPS estimate that analysts have on China Biologic Products, Inc. (NASDAQ:CBPO) for the quarter ending 2015-06-30 is $0.85.
Brokerage Firm Focus: China Biologic Products, Inc. (NASDAQ:CBPO)
The Markets Daily - Apr 16, 2015
On a consensus basis, Street analysts are expecting China Biologic Products, Inc. (NASDAQ:CBPO) to report earnings per share of $0.84 for the quarter ending 2015-03-31.
New Lifetime High Reached By China Biologic Products (CBPO)
TheStreet.com - Mar 27, 2015
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
Earnings Scope: China Biologic Products, Inc. (NASDAQ:CBPO)
Markets Daily - May 18, 2015
Sell-side analysts are expecting China Biologic Products, Inc. (NASDAQ:CBPO) to report quarterly earnings per share of $0.85 for the quarter ending 2015-06-30.
China Biologic Products, Inc. (CBPO) Jumps: Stock Surges 10.8%
Zacks.com - Jul 9, 2014
China Biologic Products, Inc. (CBPO - Snapshot Report) was a big mover last session, as the company saw its shares rise nearly 11% on the day.
China Biologic Products (CBPO) Catches Eye: Stock Up 6%
Zacks.com - Jul 9, 2014
China Biologic Products, Inc. (CBPO - Snapshot Report) was a big mover last session, as the company saw its shares rise almost 6% on the day.